VIENNA, Austria: Regedent is marking a major milestone at EuroPerio11 with a symposium highlighting ten years of clinical experience with hyaDENT BG, a cross-linked hyaluronic acid (xHyA) that has played a significant role in advancing periodontal and peri-implant therapy.